Ranbaxy Laboratories Limited

218 articles about Ranbaxy Laboratories Limited

• Ranbaxy Laboratories Highlights Improved Business and Quality Assurance Standards

  5/22/2013

• The Ranbaxy Laboratories Whistleblower and the Scheme to Fool the FDA

  5/16/2013

• Ranbaxy Laboratories Pays $500 Million to Settle Long-Running Production Scandal

  5/14/2013

• Ranbaxy Laboratories Slams Consumers for Seeking Lipitor Recall

  2/25/2013

• American Consumers Approach Court to Consider Recall of Ranbaxy Laboratories's Generic Drug Lipitor

  2/4/2013

• Ranbaxy Laboratories Implements Cegedim Relationship Management's Compliance Solution Suite to Efficiently Meet Regulatory Requirements

  1/4/2013

• Ranbaxy Laboratories to Expand Mohali Unit to Cater to U.S. Market

  12/17/2012

• Mylan Inc. Tries to Get Its Hands on Ranbaxy Laboratories' Rights Over Novartis AG's Diovan

  12/7/2012

• Ranbaxy Laboratories Halts Production of Generic Lipitor

  12/3/2012

• Ranbaxy Laboratories Recall Brings Back Painful Memories

  11/27/2012

• Ranbaxy Laboratories Launches Absorica&#0153 (Isotretinoin) Capsules in the U.S. Healthcare Market

  11/26/2012

• Ranbaxy Laboratories to Get Guidance Soon for Remedial Steps on Dewas Unit

  11/12/2012

• Ranbaxy Laboratories Misses Out on First-Day Launch of Hypertension Drug's Generic Version

  9/26/2012

• Ranbaxy Laboratories to Invest $40 Million to Set Up New Malaysia Plant; Will Provide New Jobs

  9/14/2012

• FDA Withdraws Nod to 27 Ranbaxy Laboratories ANDAs

  8/24/2012

• Lipitor Clone Gets Ranbaxy Laboratories $600 Million

  8/10/2012

• Did Ranbaxy Laboratories Abandon Generic Provigil Launch?

  8/8/2012

• Gilead Sciences, Inc. Inks Deals With 3 Indian Companies Including Ranbaxy Laboratories for Low-Cost HIV Drug

  8/3/2012

• Ranbaxy Laboratories Plans to Expand Sales in the U.S.

  7/10/2012

• Daiichi Sankyo, Inc. to Market Ranbaxy Laboratories Drugs in Venezuela

  6/21/2012